Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules

被引:9
作者
Greene, AL [1 ]
Makrigiannis, AP [1 ]
Fitzpatrick, L [1 ]
Hoskin, DW [1 ]
机构
[1] Dalhousie Univ, Fac Med, Dept Microbiol & Immunol, Halifax, NS B3H 4H7, Canada
关键词
D O I
10.1089/jir.1997.17.727
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the role of interleukin-6 (IL-6) in the induction of major histocompatibility complex (MHC)-unrestricted cytotoxicity, as well as granzyme B, perforin, and Fas ligand gene expression, following mouse T lymphocyte activation with anti-CD3 monoclonal antibody (mAb), The generation of anti-CD3-activated killer-T (AK-T) cells was inhibited when anti-IL-6 neutralizing mAb was added at initiation of culture but not 24 h later, indicating that IL-6 is involved at an early stage of AK-T cell development, However, AK-T cell induction in the presence of exogenous IL-6 did not result in enhanced cytotoxicity, suggesting that saturating levels of IL-6 are normally synthesized in AK-T cell cultures, The inhibitory effect of IL-6 neutralization on AK-T cell generation could not be attributed to a defect in AK-T cell proliferation or to an inability of AK-T cells to recognize and adhere to P815 tumor target cells, However, IL-2 synthesis and CD25 expression were downregulated in AK-T cell cultures performed in the presence of anti-IL-6 mAb, In addition, IL-6 neutralization resulted in decreased expression of granzyme B and perforin, but not Fas ligand, mRNA, Exogenous IL-2 (50 U/ml) added at initiation of culture completely reversed the inhibitory effect of anti-IL-6 mAb on AK-T cell development, restoring CD25 expression and tumoricidal activity, as well as granzyme B and perforin mRNA expression, to control levels, We conclude that IL-6 modulates AK T cell induction through an IL-2-dependent mechanism.
引用
收藏
页码:727 / 737
页数:11
相关论文
共 48 条
[1]  
AARDEN LA, 1992, CIBA F SYMP, V167, P68
[2]  
ALEGRE ML, 1991, J IMMUNOL, V146, P1184
[3]   T-CELL RECEPTOR-INDUCED FAS LIGAND EXPRESSION IN CYTOTOXIC T-LYMPHOCYTE CLONES IS BLOCKED BY PROTEIN-TYROSINE KINASE INHIBITORS AND CYCLOSPORINE-A [J].
ANEL, A ;
BUFERNE, M ;
BOYER, C ;
SCHMITTVERHULST, AM ;
GOLSTEIN, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2469-2476
[4]  
BASS HZ, 1993, J IMMUNOL, V151, P2895
[5]  
CEUPPENS JL, 1988, J IMMUNOL, V141, P3868
[6]   HIGH-AFFINITY AND LOW-AFFINITY RECEPTORS FOR MURINE INTERLEUKIN .6. DISTINCT DISTRIBUTION ON B-CELLS AND T-CELLS [J].
COULIE, PG ;
STEVENS, M ;
VANSNICK, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (11) :2107-2114
[7]  
FINKE JH, 1993, CANCER RES, V53, P5613
[8]   Anti-CD3-activated killer T cells: Interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity [J].
Fitzpatrick, L ;
Makrigiannis, AP ;
Kaiser, M ;
Hoskin, DW .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (07) :537-546
[9]   EVIDENCE THAT PRODUCTION OF INTERLEUKIN-6 WITHIN THE REJECTING ALLOGRAFT COINCIDES WITH CYTOTOXIC LYMPHOCYTE-T DEVELOPMENT [J].
FORD, HR ;
HOFFMAN, RA ;
TWEARDY, DJ ;
KISPERT, P ;
WANG, S ;
SIMMONS, RL .
TRANSPLANTATION, 1991, 51 (03) :656-661
[10]  
GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637